Training scientists in immunoengineering techniques
Immunoengineering Postdoctoral Training Program - Resubmission - 1
['FUNDING_TRAINING'] · UNIVERSITY OF CHICAGO · NIH-10875514
This program is designed to help new scientists learn about the exciting field of immunoengineering, where they will work on important research projects related to the immune system and develop skills like managing projects and writing grants, all while being guided by experienced mentors in areas like vaccines and cancer treatment.
Quick facts
| Phase | ['FUNDING_TRAINING'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10875514 on ClinicalTrials.gov |
What this research studies
This program aims to train postdoctoral scientists in the innovative field of immunoengineering, which combines immunology and bioengineering. Participants will engage in collaborative research projects that address critical questions in immunology while developing essential skills such as project management, grant writing, and science communication. The training involves mentorship from experts in various areas, including vaccines, immuno-oncology, and cellular immunology, providing a comprehensive educational experience. This interdisciplinary approach is designed to foster the next generation of scientists who can advance the field of immunoengineering.
Who could benefit from this research
Good fit: Ideal candidates for this program are postdoctoral researchers with backgrounds in bioengineering or immunology.
Not a fit: Patients who are not involved in academic or research settings may not directly benefit from this training program.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies and technologies for treating immune-related conditions.
How similar studies have performed: Similar training programs in interdisciplinary fields have shown success in advancing scientific knowledge and innovation.
Where this research is happening
CHICAGO, UNITED STATES
- UNIVERSITY OF CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SWARTZ, MELODY ANN — UNIVERSITY OF CHICAGO
- Study coordinator: SWARTZ, MELODY ANN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.